Product NDC: | 21695-325 |
Proprietary Name: | VYTORIN |
Non Proprietary Name: | ezetimibe and simvastatin |
Active Ingredient(s): | 10; 20 mg/1; mg/1 & nbsp; ezetimibe and simvastatin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-325 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021687 |
Marketing Category: | NDA |
Start Marketing Date: | 20040723 |
Package NDC: | 21695-325-30 |
Package Description: | 30 TABLET in 1 BOTTLE (21695-325-30) |
NDC Code | 21695-325-30 |
Proprietary Name | VYTORIN |
Package Description | 30 TABLET in 1 BOTTLE (21695-325-30) |
Product NDC | 21695-325 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ezetimibe and simvastatin |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040723 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | EZETIMIBE; SIMVASTATIN |
Strength Number | 10; 20 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |